Today: 9 June 2026
Lottery Corp share price rises again as ASX:TLC keeps dividend despite weak jackpots
19 February 2026
1 min read

Lottery Corp share price rises again as ASX:TLC keeps dividend despite weak jackpots

Sydney, Feb 19, 2026, 18:32 AEDT — Market shut its doors for the day.

The Lottery Corporation Limited finished Thursday at A$5.58, up 1.1%. That adds to hefty gains after earnings, with the stock now roughly 8% higher across two sessions.

This is coming into focus now as investors pick through Australia’s reporting season, looking for the so-called “defensive” earners. Lottery Corp is pitching itself on reliable cash flow and a dependable payout. In its half-year briefing, the company pointed out that the December half was its worst period for jackpot outcomes since the 2022 demerger, which shaved A$400 million off turnover (game sales)—despite digital now making up 41.2% of lottery turnover. Market Index Data API

The company reported revenue of A$1.815 billion for the six months ended Dec. 31, a 2% increase, but net profit after tax dipped 1.4% to A$173.3 million. An interim dividend of 8.0 Australian cents per share was declared, fully franked, with payment scheduled for March 26.

Chief executive Wayne Pickup pointed to the first half, noting, “This was evidenced by our ability to maintain the dividend in a historically low jackpot environment.” For FY26, the company is projecting operating expenses between A$310 million and A$320 million, with capital expenditure expected in the A$90 million to A$100 million range. The stock is set to trade ex-dividend on Feb. 25. Market Index Data API

“A quiet price rise can matter more than a record jackpot,” Graham Witcomb at Intelligent Investor said, flagging that softer Powerball and Oz Lotto jackpots during the half dented turnover. Intelligent Investor

Stocks across the board held their ground, with the S&P/ASX 200 climbing 0.88% by Thursday’s close.

Lottery Corp’s story keeps circling familiar themes: jackpot streaks that jolt ticket sales, how well those base-game price hikes hold up, and if digital growth stays strong even when there’s no giant prize drawing in the crowds.

The recent two-day bounce in the stock doesn’t erase a clearer risk on the downside. Should jackpots remain muted or expenses outpace projections, that “reliable dividend” starts to look shaky—particularly with a payout ratio already pressing against earnings.

Stock Market Today

  • Applied Materials 10-Year Investment Growth: $1000 to $20,312
    June 9, 2026, 10:25 AM EDT. A $1000 investment in Applied Materials (AMAT) made in June 2016 would be worth $20,312.42 as of June 2026, representing a 1,931.24% gain. Applied Materials, based in Santa Clara, California, supplies equipment for semiconductor device manufacturing, flat panel displays and solar PV products. Its business is divided into Semiconductor Systems, Applied Global Services, and Display segments. The company's tools support critical chipmaking processes, including deposition and implantation on silicon wafers. With over 33,000 systems installed globally, it competes mainly with equipment makers like KLAC and LRCX. This significant return highlights the potential rewards of long-term investment in semiconductor capital equipment providers.

Latest articles

Redwire Shares Slip After $500 Million Stock Offering Filed

Redwire Shares Slip After $500 Million Stock Offering Filed

9 June 2026
Redwire Corp shares plunged 6.5% to $17.37 after launching a $500 million at-the-market stock program, raising dilution risks for investors as the company seeks flexible funding despite recent record backlog and strong revenue growth; the drop contrasted with gains at other space stocks, highlighting investor concern over potential share issuance.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

9 June 2026
Nuvalent shares soared 38.9% to $122.93, just below GSK’s $124-a-share cash offer after the $10.6 billion buyout was announced, as investors bet on the deal closing with Nuvalent’s two lead lung-cancer drugs already under FDA review and a 40% premium to the last closing price driving the morning’s merger-arb trade.
Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe
Previous Story

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe

Tesco share price nudges toward 52-week high after UK retail sales jump — what to watch next
Next Story

Tesco share price nudges toward 52-week high after UK retail sales jump — what to watch next

Go toTop